Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,889,749 | 2,625,592 | 1,970,335 | 1,575,794 | -1,189,957 |
| Depreciation Amortization | 265,477 | 212,944 | 155,610 | 101,360 | 47,284 |
| Income taxes - deferred | 12,152 | -42,013 | -24,969 | 113,384 | -9,220 |
| Accounts receivable | -348,875 | -356,462 | -257,161 | -138,034 | -184,370 |
| Accounts payable and accrued liabilities | -4,453 | 203,641 | 312,568 | -77,549 | 263,965 |
| Other Working Capital | -680,380 | 30,209 | -128,130 | -332,381 | -286,169 |
| Other Operating Activity | 700,243 | 406,143 | 115,131 | 426,508 | 2,576,526 |
| Operating Cash Flow | $2,833,913 | $3,080,054 | $2,143,384 | $1,669,082 | $1,218,059 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,784,867 | -738,027 | -52,963 | -1,172,376 | 1,110,698 |
| PPE Investments | -61,884 | -230,057 | -115,005 | -78,648 | -105,208 |
| Net Acquisitions | -91,000 | -1,247,816 | -10,851 | -46,443 | -2,736,172 |
| Purchase Of Investment | N/A | N/A | N/A | -5,000 | -8,652 |
| Investing Cash Flow | $-1,937,751 | $-2,215,900 | $-178,819 | $-1,302,467 | $-1,739,334 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,962,500 | 400,000 | N/A | N/A | 1,276,242 |
| Debt Repayment | -868,408 | -711,103 | -4,326 | -99,459 | -580,684 |
| Common Stock Issued | 376,648 | 222,728 | 246,125 | 243,427 | 403,386 |
| Common Stock Repurchased | -4,022,593 | -998,495 | -1,969,582 | -487,543 | -544,942 |
| Other Financing Activity | 213,143 | 35,432 | 253,214 | 172,592 | 95,259 |
| Financing Cash Flow | $-1,338,710 | $-1,051,438 | $-1,474,569 | $-170,983 | $649,261 |
| Exchange Rate Effect | 77,469 | 940 | 1,220 | -43,553 | -19,892 |
| Beginning Cash Position | 1,272,958 | 1,459,302 | 968,086 | 816,007 | 707,913 |
| End Cash Position | 907,879 | 1,272,958 | 1,459,302 | 968,086 | 816,007 |
| Net Cash Flow | $-365,079 | $-186,344 | $491,216 | $152,079 | $108,094 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,833,913 | 3,080,054 | 2,143,384 | 1,669,082 | 1,218,059 |
| Capital Expenditure | -61,884 | -230,057 | -115,005 | -78,648 | -105,208 |
| Free Cash Flow | 2,772,029 | 2,849,997 | 2,028,379 | 1,590,434 | 1,112,851 |